Columnists
Tipsheet
Cartoons
Podcasts
Newsletters
Sections
Podcasts
Townhall TV
Election
Capitol Voices
Entertainment
Radio News
Live Blog
Topics
Sites
Hot Air
PJ Media
Bearing Arms
Twitchy
RedState
JOIN VIP
LOGIN
MY ACCOUNT
Account Settings
Newsletter Subscriptions
Log Out
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
G1 Therapeutics Inc
(NQ:
GTHX
)
7.100
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 21, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about G1 Therapeutics Inc
< Previous
1
2
3
4
5
6
Next >
Why Frequency Therapeutics Are Trading Lower By 82%? Here Are Other Stocks Moving In Monday's Mid-Day Session
February 13, 2023
Gainers Vallon Pharmaceuticals, Inc. (NASDAQ: VLON) shares jumped 120.5% to $1.02 after jumping over 72% on Friday.
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
February 13, 2023
Via
Benzinga
Nasdaq Rises 1.5%; G1 Therapeutics Shares Plummet
February 13, 2023
U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining around 1.5% on Monday. The Dow traded up 0.96% to 34,193.83 while the NASDAQ rose 1.52% to 11,896.75. The S&P 500...
Via
Benzinga
G1 Therapeutics Reveals An Early Cut Data From Bladder Cancer Trial
January 04, 2023
Via
Benzinga
Earnings Scheduled For March 1, 2023
March 01, 2023
Companies Reporting Before The Bell • Globalstar (AMEX:GSAT) is expected to report quarterly loss at $0.01 per share on revenue of $38.75 million.
Via
Benzinga
G1 Therapeutics Provides Fourth Quarter and Full Year 2022 Financial Results and Operational Highlights
March 01, 2023
From
G1 Therapeutics
Via
GlobeNewswire
G1 Therapeutics's Earnings Outlook
February 28, 2023
Via
Benzinga
Dow Gains Over 300 Points; S&P 500 Up 1%
February 13, 2023
U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining over 300 points on Monday. The Dow traded up 1.01% to 34,211.29 while the NASDAQ rose 1.52% to 11,896.33. The S&P 500...
Via
Benzinga
Stocks That Hit 52-Week Lows On Monday
February 13, 2023
On Monday, 42 companies hit new 52-week lows.
Via
Benzinga
US Stocks Open Higher; Dow Jumps 200 Points
February 13, 2023
U.S. stocks traded higher this morning, with the Dow Jones gaining around 200 points on Monday. Following the market opening Monday, the Dow traded up 0.59% to 34,069.23 while the NASDAQ rose 0.65% to...
Via
Benzinga
Why Is Monday.com (MNDY) Stock Up 11% Today?
February 13, 2023
Monday.com (MNDY) stock is on the rise Monday after announcing a partnership with Appfire to expand its app marketplace.
Via
InvestorPlace
NVAX Stock Alert: Novavax Will Provide 1.5 Million More Covid-19 Vaccine Doses to U.S.
February 13, 2023
Novavax (NVAX) stock is on the move Monday after extending its Covid-19 vaccine supply agreement with the U.S. government.
Via
InvestorPlace
Why Is Sorrento Therapeutics (SRNE) Stock Down 40% Today?
February 13, 2023
Sorrento Therapeutics (SRNE) stock is falling on Monday after the company filed for bankruptcy alongside Scintilla Pharmaceuticals.
Via
InvestorPlace
Why Is G1 Therapeutics (GTHX) Stock Down 52% Today?
February 13, 2023
G1 Therapeutics (GTHX) stock is falling on Monday after the company announced plans to discontinue a Phase 3 clinical trial.
Via
InvestorPlace
12 Health Care Stocks Moving In Monday's Pre-Market Session
February 13, 2023
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
February 13, 2023
It's time to start the week with a breakdown of the biggest pre-market stock movers traders will want to keep a watch on Monday!
Via
InvestorPlace
G1 Therapeutics Shelves Pivotal Colorectal Trial, After Trilaciclib Triplet Therapy Favored Placebo Arm
February 13, 2023
Via
Benzinga
G1 Therapeutics Announces Top Line Results from Pivotal Phase 3 Trial of Trilaciclib in Patients Receiving Triplet Therapy with FOLFOXIRI + Bevacizumab for Metastatic Colorectal Cancer (CRC) (PRESERVE 1)
February 13, 2023
From
G1 Therapeutics
Via
GlobeNewswire
Benzinga's Top Ratings Upgrades, Downgrades For January 30, 2023
January 30, 2023
Via
Benzinga
G1 Therapeutics Announces Upcoming 2023 Readouts from its Phase 2 and Pivotal Phase 3 Clinical Trials of Trilaciclib
January 09, 2023
From
G1 Therapeutics
Via
GlobeNewswire
Initial Results from Phase 2 Mechanism of Action Trial in Early-Stage Triple Negative Breast Cancer Show that a Single Dose of Trilaciclib Favorably Alters the Tumor Microenvironment
December 07, 2022
From
G1 Therapeutics
Via
GlobeNewswire
Benzinga's Top Ratings Upgrades, Downgrades For January 5, 2023
January 05, 2023
Via
Benzinga
Big Developments Set to be Unveiled at This Year’s San Antonio Breast Cancer Symposium (SABCS)
November 30, 2022
EQNX::TICKER_START (NASDAQ:ONCY),(NYSE:LLY),(NASDAQ:NEO),(NYSE:ZYME),(NASDAQ:GTHX) EQNX::TICKER_END
Via
FinancialNewsMedia
G1 Therapeutics Announces Closing of Offering of Common Stock
November 22, 2022
From
G1 Therapeutics
Via
GlobeNewswire
Nasdaq Down 0.5%; Clearfield Shares Spike Higher
November 18, 2022
U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite dropping over 50 points on Friday.
Via
Benzinga
Why InMed Pharmaceuticals Shares Tumbled 28%; Here Are 67 Biggest Movers From Friday
November 21, 2022
Gainers AGBA Group Holding Limited (NASDAQ: AGBA) gained 50.7% to close at $6.78 on Friday.
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
November 18, 2022
Via
Benzinga
Why PaxMedica Shares Are Trading Higher By Over 53%? Here Are 47 Stocks Moving In Friday's Mid-Day Session
November 18, 2022
Gainers PaxMedica, Inc. (NASDAQ: PXMD) gained 53.5% to $2.38 after the company announced an equity investment agreement for up to $20 million with Lincoln Park Capital.
Via
Benzinga
Nasdaq Turns Lower; Crude Oil Down Over 3%
November 18, 2022
U.S. stocks traded mixed midway through trading, with the Nasdaq Composite turning lower on Friday.
Via
Benzinga
Delta Apparel, Farfetch, American Software And Some Other Big Stocks Moving Lower On Friday
November 18, 2022
U.S. stocks traded mixed, with the Dow Jones gaining more than 80 points on Friday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
< Previous
1
2
3
4
5
6
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.